申请人:GILEAD SCIENCES, INC.
公开号:US20190282576A1
公开(公告)日:2019-09-19
The present disclosure relates generally to toll like receptor modulator compounds, such as diamino pyrido[3,2 D] pyrimidine compounds and pharmaceutical compositions which, among other things, modulate toll-like receptors (e.g. TLR-8), and methods of making and using them.